Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Hyperinsulinism D006946 27 associated lipids
Brain Diseases D001927 27 associated lipids
Gastritis D005756 27 associated lipids
Mammary Neoplasms, Animal D015674 27 associated lipids
Gastrointestinal Hemorrhage D006471 27 associated lipids
Ventricular Remodeling D020257 28 associated lipids
Neuralgia D009437 28 associated lipids
Vitamin E Deficiency D014811 29 associated lipids
Endometrial Neoplasms D016889 30 associated lipids
Proteinuria D011507 30 associated lipids
Cardiomegaly D006332 31 associated lipids
Hypertension, Pulmonary D006976 32 associated lipids
Stroke D020521 32 associated lipids
Neurodegenerative Diseases D019636 32 associated lipids
Thyroid Neoplasms D013964 33 associated lipids
Memory Disorders D008569 33 associated lipids
Acute Lung Injury D055371 33 associated lipids
Uremia D014511 33 associated lipids
Acute Kidney Injury D058186 34 associated lipids
Spinal Cord Injuries D013119 34 associated lipids
Anemia, Sickle Cell D000755 34 associated lipids
Burns D002056 34 associated lipids
Glomerulonephritis D005921 35 associated lipids
Anaphylaxis D000707 35 associated lipids
Epilepsy D004827 35 associated lipids
Infarction, Middle Cerebral Artery D020244 35 associated lipids
Fever D005334 35 associated lipids
Liver Cirrhosis, Experimental D008106 36 associated lipids
Nervous System Diseases D009422 37 associated lipids
Lung Diseases D008171 37 associated lipids
Peritonitis D010538 38 associated lipids
Zellweger Syndrome D015211 39 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Diabetic Retinopathy D003930 39 associated lipids
Hypotension D007022 41 associated lipids
Leukemia, Erythroblastic, Acute D004915 41 associated lipids
Arthritis D001168 41 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Hyperalgesia D006930 42 associated lipids
Leukemia, Experimental D007942 42 associated lipids
Ischemic Attack, Transient D002546 42 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Hypersensitivity, Delayed D006968 43 associated lipids
Metabolic Syndrome D024821 44 associated lipids
Metabolism, Inborn Errors D008661 46 associated lipids
Psoriasis D011565 47 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Thrombosis D013927 49 associated lipids
Osteosarcoma D012516 50 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Zhang GQ et al. [The effects of milkvetch and memantain on the synthesis of cerebral PAF in neonatal rats with hypoxic-ischemic reperfusion]. 2003 Zhonghua Er Ke Za Zhi pmid:14751060
Mayerle J et al. [Conservative treatment of acute pancreatitis]. 2003 Med. Klin. (Munich) pmid:14685675
Saeed SA and Rasheed H Calcium-dependent synergistic interaction of platelet activating factor and epinephrine in human platelet aggregation. 2003 Acta Pharmacol. Sin. pmid:12511226
Russo S et al. Platelet-activating factor mediates CD40-dependent angiogenesis and endothelial-smooth muscle cell interaction. 2003 J. Immunol. pmid:14607955
Slomiany BL and Slomiany A Biphasic role of platelet-activating factor in oral mucosal ulcer healing. 2003 IUBMB Life pmid:14609204
Shigematsu S et al. Resveratrol, a red wine constituent polyphenol, prevents superoxide-dependent inflammatory responses induced by ischemia/reperfusion, platelet-activating factor, or oxidants. 2003 Free Radic. Biol. Med. pmid:12654468
Zhang Y et al. Antioxidant superoxide dismutase attenuates increased endothelial permeability induced by platelet-activating factor. 2003 J. Soc. Gynecol. Investig. pmid:12517587
Collado MP et al. Endothelin-1 decreases ethanolamine plasmalogen levels and evokes PAF production in brain microvessels. 2003 Microvasc. Res. pmid:14609525
Odeh AI et al. Effect of platelet-activating factor (PAF) on stallion sperm motility, capacitation and the acrosome reaction. 2003 Reproduction pmid:14611633
Kuo RY et al. Antiplatelet activity of benzylisoquinoline derivatives oxidized by cerium(IV) ammonium nitrate. 2003 Bioorg. Med. Chem. Lett. pmid:12873516
Sugimoto Y et al. Inhibitory effects of glucocorticoids on rat eosinophil superoxide generation and chemotaxis. 2003 Int. Immunopharmacol. pmid:12781701
Yang Y et al. Kupffer cells are a major source of increased platelet activating factor in the CCl4-induced cirrhotic rat liver. 2003 J. Hepatol. pmid:12873816
Biffl WL et al. Clinically relevant hypertonicity prevents stored blood- and lipid-mediated delayed neutrophil apoptosis independent of p38 MAPK or caspase-3 activation. 2003 Surgery pmid:12874587
Akisu M et al. Selective head cooling with hypothermia suppresses the generation of platelet-activating factor in cerebrospinal fluid of newborn infants with perinatal asphyxia. 2003 Prostaglandins Leukot. Essent. Fatty Acids pmid:12878450
Gabrijelcic J et al. Neutrophil airway influx by platelet-activating factor in asthma: role of adhesion molecules and LTB4 expression. 2003 Eur. Respir. J. pmid:12952263
Takafuji S et al. Matrix metalloproteinase-9 release from human leukocytes. 2003 J Investig Allergol Clin Immunol pmid:12861851
Bar-Or D et al. Copper stimulates the synthesis and release of interleukin-8 in human endothelial cells: a possible early role in systemic inflammatory responses. 2003 Shock pmid:12865660
Kujiraoka T et al. Altered distribution of plasma PAF-AH between HDLs and other lipoproteins in hyperlipidemia and diabetes mellitus. 2003 J. Lipid Res. pmid:12867534
D'Andrea D et al. Induction of tissue factor in the arterial wall during recurrent thrombus formation. 2003 Arterioscler. Thromb. Vasc. Biol. pmid:12869352
Lupia E et al. The membrane attack complex of complement contributes to plasmin-induced synthesis of platelet-activating factor by endothelial cells and neutrophils. 2003 Immunology pmid:12871223
Fernandes ES et al. Mechanisms underlying the modulatory action of platelet activating factor (PAF) on the upregulation of kinin B1 receptors in the rat paw. 2003 Br. J. Pharmacol. pmid:12839871
Saruc M et al. An experimental model of hemolysis-induced acute pancreatitis. 2003 Braz. J. Med. Biol. Res. pmid:12845374
Nomikos TN et al. Acetyl-CoA:1-O-alkyl-sn-glycero-3-phosphocholine acetyltransferase (lyso-PAF AT) activity in cortical and medullary human renal tissue. 2003 Eur. J. Biochem. pmid:12846832
Suzuki M et al. Actin assembly is a crucial factor for superoxide anion generation from adherent human eosinophils. 2003 J. Allergy Clin. Immunol. pmid:12847489
Casillan AJ et al. Mesenteric microvascular inflammatory responses to systemic hypoxia are mediated by PAF and LTB4. 2003 J. Appl. Physiol. pmid:12598480
Liu J et al. Lipopolysaccharide induces anandamide synthesis in macrophages via CD14/MAPK/phosphoinositide 3-kinase/NF-kappaB independently of platelet-activating factor. 2003 J. Biol. Chem. pmid:12949078
Rios-Santos F et al. A critical role of leukotriene B4 in neutrophil migration to infectious focus in cecal ligaton and puncture sepsis. 2003 Shock pmid:12558146
Mano T et al. Novel imidazole compounds as a new series of potent, orally active inhibitors of 5-lipoxygenase. 2003 Bioorg. Med. Chem. pmid:12927848
Talvani A et al. Experimental Trypanosoma cruzi infection in platelet-activating factor receptor-deficient mice. 2003 Microbes Infect. pmid:12850205
Triggiani M et al. Secretory phospholipases A2 activate selective functions in human eosinophils. 2003 J. Immunol. pmid:12626587
Strait RT et al. IL-4 exacerbates anaphylaxis. 2003 J. Immunol. pmid:12646651
Al-Darmaki S et al. Differential expression of platelet-activating factor acetylhydrolase in macrophages and monocyte-derived dendritic cells. 2003 J. Immunol. pmid:12496397
Lukashova V et al. Janus kinase 2 activation by the platelet-activating factor receptor (PAFR): roles of Tyk2 and PAFR C terminus. 2003 J. Immunol. pmid:14500680
Lie WJ et al. Regulation and kinetics of platelet-activating factor and leukotriene C4 synthesis by activated human basophils. 2003 Clin. Exp. Allergy pmid:12911788
Kusunoki H et al. Relation between serum 3-deoxyglucosone and development of diabetic microangiopathy. 2003 Diabetes Care pmid:12766129
Strümper D et al. Effects of antidepressants on function and viability of human neutrophils. 2003 Anesthesiology pmid:12766643
Pizurki L et al. Angiopoietin-1 inhibits endothelial permeability, neutrophil adherence and IL-8 production. 2003 Br. J. Pharmacol. pmid:12770938
Takizawa T et al. Distinct isoforms of protein kinase C are involved in human eosinophil functions induced by platelet-activating factor. 2003 Int. Arch. Allergy Immunol. pmid:12771544
Fernandes LB and Goldie RG The single mediator approach to asthma therapy: is it so unreasonable? 2003 Curr Opin Pharmacol pmid:12810188
Zhang X et al. Age-related increase of plasma platelet-activating factor concentrations in Chinese. 2003 Clin. Chim. Acta pmid:14568193
Watanabe J et al. Endotoxins stimulate neutrophil adhesion followed by synthesis and release of platelet-activating factor in microparticles. 2003 J. Biol. Chem. pmid:12810708
De Vriese AS and Bourgeois M Pharmacologic treatment of acute renal failure in sepsis. 2003 Curr Opin Crit Care pmid:14639066
Alviano DS et al. Differentiation of Fonsecaea pedrosoi mycelial forms into sclerotic cells is induced by platelet-activating factor. 2003 Res. Microbiol. pmid:14643407
Chlopicki S et al. Obligatory role of lipid mediators in platelet-neutrophil adhesion. 2003 Thromb. Res. pmid:14592550
Montrucchio G et al. Mechanisms of the priming effect of low doses of lipopoly-saccharides on leukocyte-dependent platelet aggregation in whole blood. 2003 Thromb. Haemost. pmid:14597983
Shabanov VV [Cytokines and other signal molecules in the pathogenesis of acute pancreatitis]. 2003 Vestn. Akad. Med. Nauk SSSR pmid:14598737
Estellés R et al. Effect of two phenanthrene alkaloids on angiotensin II-induced leukocyte-endothelial cell interactions in vivo. 2003 Br. J. Pharmacol. pmid:14559857
Kell PJ et al. Inhibition of platelet-activating factor (PAF) acetylhydrolase by methyl arachidonyl fluorophosphonate potentiates PAF synthesis in thrombin-stimulated human coronary artery endothelial cells. 2003 J. Pharmacol. Exp. Ther. pmid:14560038
Denizot Y et al. Tissue concentrations of platelet-activating factor in colorectal carcinoma: inverse relationships with Dukes' stage of patients. 2003 Oncogene pmid:14562051
Ivanov AI et al. Platelet-activating factor: a previously unrecognized mediator of fever. 2003 J. Physiol. (Lond.) pmid:14565987
Cole KP and Hsung RP Intramolecular formal oxa-[3 + 3] cycloaddition approach to the ABD system of phomactin A. 2003 Org. Lett. pmid:14653688
Hao J et al. [Dynamic changes of platelet number in early multiple injury and it is effect on prognosis]. 2003 Zhongguo Wei Zhong Bing Ji Jiu Yi Xue pmid:14552687
Elovitz MA et al. A new model for inflammation-induced preterm birth: the role of platelet-activating factor and Toll-like receptor-4. 2003 Am. J. Pathol. pmid:14578208
Kogure K et al. Temporary membrane distortion of vascular smooth muscle cells is responsible for their apoptosis induced by platelet-activating factor-like oxidized phospholipids and their degradation product, lysophosphatidylcholine. 2003 Chem. Phys. Lipids pmid:14580708
Bernatchez PN et al. Sphingosine 1-phosphate effect on endothelial cell PAF synthesis: role in cellular migration. 2003 J. Cell. Biochem. pmid:14587028
Saraf MK et al. Role of platelet activating factor in triazolobenzodiazepines-induced retrograde amnesia. 2003 Behav. Brain Res. pmid:12798263
Denizot Y et al. Platelet-activating factor and normal or leukaemic haematopoiesis. 2003 Leuk. Lymphoma pmid:12802913
Olanders K et al. Protective effects of N-acetyl-L-cysteine and platelet activating factor inhibition are not linked to intercellular adhesion molecule-1 expression after intestinal ischemia and reperfusion injury in rats. 2003 Scand. J. Gastroenterol. pmid:12825870
Adamson RH et al. PAF- and bradykinin-induced hyperpermeability of rat venules is independent of actin-myosin contraction. 2003 Am. J. Physiol. Heart Circ. Physiol. pmid:12649070
Haraldsen P et al. Multimodal management - of value in fulminant acute pancreatitis? 2003 Pancreatology pmid:12649560
Denizot Y et al. No evidence for a putative involvement of platelet-activating factor in systemic lupus erythematosus without active nephritis. 2003 Mediators Inflamm. pmid:12775360
Yan W et al. Previously uncharacterized roles of platelet-activating factor acetylhydrolase 1b complex in mouse spermatogenesis. 2003 Proc. Natl. Acad. Sci. U.S.A. pmid:12775763
Nie ZG and Wang WJ [Effect of ginkgolide B on platelet-activating factor induced activation of rat polymorphonuclear leukocytes]. 2003 Yao Xue Xue Bao pmid:12778742
Fragopoulou E et al. Structure elucidation of phenolic compounds from red/white wine with antiatherogenic properties. 2003 Biochim. Biophys. Acta pmid:12782155
Marshall JC Such stuff as dreams are made on: mediator-directed therapy in sepsis. 2003 Nat Rev Drug Discov pmid:12750742
Bayar MA et al. The effect of EGb-761 on morphologic vasospasm in canine basilar artery after subarachnoid hemorrhage. 2003 J. Cardiovasc. Pharmacol. pmid:12960685
Kato M et al. The role of platelet activating factor and the efficacy of apafant ophthalmic solution in experimental allergic conjunctivitis. 2003 J Ocul Pharmacol Ther pmid:12964956
Ishiura Y et al. Airway eosinophil accumulation on sensory neuropeptide release in a guinea pig model of distilled-water-induced bronchoconstriction. 2003 J Investig Allergol Clin Immunol pmid:12968390
Calabresi L et al. Endothelial protection by high-density lipoproteins: from bench to bedside. 2003 Arterioscler. Thromb. Vasc. Biol. pmid:12969988
Zhao XY et al. [Effects of BIO-1211 on eosinophil chemotaxis, recruitment and mediator release]. 2003 Zhejiang Da Xue Xue Bao Yi Xue Ban pmid:12970925
Izquierdo I et al. Rupatadine: a new selective histamine H1 receptor and platelet-activating factor (PAF) antagonist. A review of pharmacological profile and clinical management of allergic rhinitis. 2003 Drugs Today pmid:12944997
Zang BX et al. [Antagonistic effect of myricetin on platelet activing factor]. 2003 Yao Xue Xue Bao pmid:14991995
Benelli R et al. Neutrophils and angiogenesis: potential initiators of the angiogenic cascade. 2003 Chem Immunol Allergy pmid:12947984
Peri A et al. The effects of an autocrine loop mediated by platelet-activating factor (PAF) in HEC-1A cells are reverted by uteroglobin. 2003 Hum. Cell pmid:15005239
Wu B et al. Platelet-activating factor promotes mucosal apoptosis via FasL-mediating caspase-9 active pathway in rat small intestine after ischemia-reperfusion. 2003 FASEB J. pmid:12709415
Bussolati B et al. The long pentraxin PTX3 is synthesized in IgA glomerulonephritis and activates mesangial cells. 2003 J. Immunol. pmid:12538709
Hou X et al. Increased platelet-activating factor-induced periventricular brain microvascular constriction associated with immaturity. 2003 Am. J. Physiol. Regul. Integr. Comp. Physiol. pmid:12626359
Hirayama K et al. Platelet-activating factor, a critical mediator in the pathogenesis of dextran sulfate sodium-induced colitis in rats. 2003 Dis. Colon Rectum pmid:12544529
Balestrieri ML et al. Modulation by flavonoids of PAF and related phospholipids in endothelial cells during oxidative stress. 2003 J. Lipid Res. pmid:12576520
Lee JM et al. Identification of the NF-E2-related factor-2-dependent genes conferring protection against oxidative stress in primary cortical astrocytes using oligonucleotide microarray analysis. 2003 J. Biol. Chem. pmid:12556532
Handa RK et al. Platelet-activating factor and solute transport processes in the kidney. 2003 Am. J. Physiol. Renal Physiol. pmid:12529272
Zhao H et al. Influence of platelet activating factor on expression of adhesion molecules in experimental pancreatitis. 2003 World J. Gastroenterol. pmid:12532462
Kolko M et al. Neuronal damage by secretory phospholipase A2: modulation by cytosolic phospholipase A2, platelet-activating factor, and cyclooxygenase-2 in neuronal cells in culture. 2003 Neurosci. Lett. pmid:12566178
Vogensen SB et al. Preparation of 7-substituted ginkgolide derivatives: potent platelet activating factor (PAF) receptor antagonists. 2003 J. Med. Chem. pmid:12570381
Chen L et al. [Determination of platelet activating factor in middle ear effusion of patients with secretory oitits media]. 2003 Lin Chuang Er Bi Yan Hou Ke Za Zhi pmid:14727433
Dinarello CA The IL-1 family and inflammatory diseases. 2002 Sep-Oct Clin. Exp. Rheumatol. pmid:14989423
Chłopicki S et al. Hypoxic pulmonary vasoconstriction in isolated blood-perfused rat lung; modulation by thromboxane A2, platelet-activating factor, cysteinyl leukotrienes and endothelin-1. 2002 Sep-Oct Pol J Pharmacol pmid:12593530
Klabunde RE and Anderson DE Role of nitric oxide and reactive oxygen species in platelet-activating factor-induced microvascular leakage. 2002 May-Jun J. Vasc. Res. pmid:12097822
Huang JB et al. Hexokinase translocation during neutrophil activation, chemotaxis, and phagocytosis: disruption by cytochalasin D, dexamethasone, and indomethacin. 2002 Jul-Aug Cell. Immunol. pmid:12470617
Levine AS et al. A review of the effect of platelet-activating factor on male reproduction and sperm function. 2002 Jul-Aug J. Androl. pmid:12065449
Farbiszewski R et al. [The role of platelet activating factor (PAF) in physiology and pathology of the central nervous system]. 2002 Jul-Aug Neurol. Neurochir. Pol. pmid:12418143
Barbuti A et al. Block of the background K(+) channel TASK-1 contributes to arrhythmogenic effects of platelet-activating factor. 2002 Am. J. Physiol. Heart Circ. Physiol. pmid:12003807
Kolaczkowska E et al. Early vascular permeability in murine experimental peritonitis is co-mediated by resident peritoneal macrophages and mast cells: crucial involvement of macrophage-derived cysteinyl-leukotrienes. 2002 Inflammation pmid:11989789
Teather LA et al. Platelet-activating factor increases prostaglandin E(2) release from astrocyte-enriched cortical cell cultures. 2002 Brain Res. pmid:12133598
De Plaen IG et al. Endotoxin, but not platelet-activating factor, activates nuclear factor-kappaB and increases IkappaBalpha and IkappaBbeta turnover in enterocytes. 2002 Immunology pmid:12153521
Kingston JK et al. Measurement of the activation of equine platelets by use of fluorescent-labeled annexin V, anti-human fibrinogen antibody, and anti-human thrombospondin antibody. 2002 Am. J. Vet. Res. pmid:11939312
Deo DD et al. Phosphorylation of STAT-3 in response to basic fibroblast growth factor occurs through a mechanism involving platelet-activating factor, JAK-2, and Src in human umbilical vein endothelial cells. Evidence for a dual kinase mechanism. 2002 J. Biol. Chem. pmid:11940567
Michibayashi T Platelet aggregating response to platelet activating factor participates in activation of the 12-lipoxygenase pathway in platelets from rabbits. 2002 Int Angiol pmid:12384648
Shigematsu S et al. Bradykinin-induced proinflammatory signaling mechanisms. 2002 Am. J. Physiol. Heart Circ. Physiol. pmid:12388246
Walterscheid JP et al. Platelet-activating factor, a molecular sensor for cellular damage, activates systemic immune suppression. 2002 J. Exp. Med. pmid:11805144